NM_000055.4:c.293A>G

Variant summary

Our verdict is Uncertain significance. The variant received 4 ACMG points: 5P and 1B. PS3PP5BP4

The NM_000055.4(BCHE):​c.293A>G​(p.Asp98Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.016 in 1,613,944 control chromosomes in the GnomAD database, including 246 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). ClinVar reports functional evidence for this variant: "SCV000967600: "In vitro functional studies provide evidence that the p.Asp98Gly variant impacts BCHE enzyme activity." PMID:9047329, PMID:27551784" and additional evidence is available in ClinVar.

Frequency

Genomes: š‘“ 0.012 ( 18 hom., cov: 32)
Exomes š‘“: 0.016 ( 228 hom. )

Consequence

BCHE
NM_000055.4 missense

Scores

4
8
5

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:21B:1O:3

Conservation

PhyloP100: 7.23

Publications

130 publications found
Variant links:
Genes affected
BCHE (HGNC:983): (butyrylcholinesterase) This gene encodes a cholinesterase enzyme and member of the type-B carboxylesterase/lipase family of proteins. The encoded enzyme exhibits broad substrate specificity and is involved in the detoxification of poisons including organophosphate nerve agents and pesticides, and the metabolism of drugs including cocaine, heroin and aspirin. Humans homozygous for certain mutations in this gene exhibit prolonged apnea after administration of the muscle relaxant succinylcholine. [provided by RefSeq, Jul 2016]
LINC01322 (HGNC:50528): (long intergenic non-protein coding RNA 1322)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 4 ACMG points.

PS3
PS3 evidence extracted from ClinVar submissions: SCV000967600: "In vitro functional studies provide evidence that the p.Asp98Gly variant impacts BCHE enzyme activity." PMID:9047329, PMID:27551784; SCV001370742: Experimental evidence evaluating an impact on protein function demonstrated the variant negatively affects enzyme activity and concentration, causing a reduction in substrate affinity and an abolition of substrate activation (e.g. Delacour_2014, Lockridge_2016, Masson_1999).; SCV004046421: Functional studies suggest the c.293A>G (p.Asp98Gly) variant leads to reduced enzyme activity and binding affinity for succinylcholine (PMID: 25448037, 2915989).; SCV002004685: Published functional studies demonstrate a severe reduction in affinity for butyrylthiocholine and succinyldithiocholine (PMID: 9047329, 23123771); SCV003799857: Functional studies show the variant causes reduced enzyme activity and a reduction in substrate affinity/activation (Delacour 2014, Lockridge 2016, Masson 1999). PMID: 25054547 PMID: 27551784 PMID: 10446378
PP5
Variant 3-165830741-T-C is Pathogenic according to our data. Variant chr3-165830741-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 13215.
BP4
Computational evidence support a benign effect (MetaRNN=0.006447643). . Strength limited to SUPPORTING due to the PP5.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000055.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BCHE
NM_000055.4
MANE Select
c.293A>Gp.Asp98Gly
missense
Exon 2 of 4NP_000046.1P06276
BCHE
NR_137636.2
n.411A>G
non_coding_transcript_exon
Exon 2 of 5
BCHE
NR_137635.2
n.110+6573A>G
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BCHE
ENST00000264381.8
TSL:1 MANE Select
c.293A>Gp.Asp98Gly
missense
Exon 2 of 4ENSP00000264381.3P06276
BCHE
ENST00000479451.5
TSL:1
c.107+6573A>G
intron
N/AENSP00000418325.1H0Y885
BCHE
ENST00000855337.1
c.293A>Gp.Asp98Gly
missense
Exon 2 of 5ENSP00000525396.1

Frequencies

GnomAD3 genomes
AF:
0.0125
AC:
1897
AN:
152168
Hom.:
18
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00364
Gnomad AMI
AF:
0.0143
Gnomad AMR
AF:
0.0131
Gnomad ASJ
AF:
0.0164
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00186
Gnomad FIN
AF:
0.0135
Gnomad MID
AF:
0.0443
Gnomad NFE
AF:
0.0187
Gnomad OTH
AF:
0.0186
GnomAD2 exomes
AF:
0.0121
AC:
3044
AN:
250996
AF XY:
0.0125
show subpopulations
Gnomad AFR exome
AF:
0.00369
Gnomad AMR exome
AF:
0.00905
Gnomad ASJ exome
AF:
0.0174
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.0123
Gnomad NFE exome
AF:
0.0179
Gnomad OTH exome
AF:
0.0173
GnomAD4 exome
AF:
0.0164
AC:
23967
AN:
1461658
Hom.:
228
Cov.:
32
AF XY:
0.0161
AC XY:
11725
AN XY:
727124
show subpopulations
African (AFR)
AF:
0.00293
AC:
98
AN:
33442
American (AMR)
AF:
0.00922
AC:
412
AN:
44672
Ashkenazi Jewish (ASJ)
AF:
0.0165
AC:
432
AN:
26120
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39694
South Asian (SAS)
AF:
0.00363
AC:
313
AN:
86250
European-Finnish (FIN)
AF:
0.0115
AC:
614
AN:
53410
Middle Eastern (MID)
AF:
0.0257
AC:
148
AN:
5766
European-Non Finnish (NFE)
AF:
0.0190
AC:
21079
AN:
1111918
Other (OTH)
AF:
0.0144
AC:
869
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
1502
3003
4505
6006
7508
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
818
1636
2454
3272
4090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0124
AC:
1894
AN:
152286
Hom.:
18
Cov.:
32
AF XY:
0.0121
AC XY:
901
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.00363
AC:
151
AN:
41570
American (AMR)
AF:
0.0131
AC:
200
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.0164
AC:
57
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00207
AC:
10
AN:
4828
European-Finnish (FIN)
AF:
0.0135
AC:
143
AN:
10608
Middle Eastern (MID)
AF:
0.0408
AC:
12
AN:
294
European-Non Finnish (NFE)
AF:
0.0187
AC:
1269
AN:
68018
Other (OTH)
AF:
0.0184
AC:
39
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
98
196
293
391
489
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0162
Hom.:
93
Bravo
AF:
0.0124
TwinsUK
AF:
0.0191
AC:
71
ALSPAC
AF:
0.0179
AC:
69
ESP6500AA
AF:
0.00227
AC:
10
ESP6500EA
AF:
0.0199
AC:
171
ExAC
AF:
0.0121
AC:
1465
Asia WGS
AF:
0.00289
AC:
10
AN:
3478
EpiCase
AF:
0.0211
EpiControl
AF:
0.0195

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
12
-
-
Deficiency of butyrylcholinesterase (15)
7
-
1
not provided (8)
1
-
-
BCHE-related disorder (1)
1
-
-
Postanesthetic apnea (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.43
BayesDel_addAF
Benign
-0.0050
T
BayesDel_noAF
Pathogenic
0.23
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.59
D
Eigen
Uncertain
0.34
Eigen_PC
Uncertain
0.34
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.87
D
MetaRNN
Benign
0.0064
T
MetaSVM
Benign
-0.30
T
MutationAssessor
Benign
1.9
M
PhyloP100
7.2
PrimateAI
Benign
0.48
T
PROVEAN
Pathogenic
-5.6
D
REVEL
Uncertain
0.56
Sift
Pathogenic
0.0
D
Sift4G
Uncertain
0.0040
D
Polyphen
0.69
P
Vest4
0.27
MPC
0.11
ClinPred
0.062
T
GERP RS
5.8
Varity_R
0.92
gMVP
0.74
Mutation Taster
=74/26
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1799807; hg19: chr3-165548529; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.